MedTrace Logo

Non-vitamin K Oral Anticoagulants in Cardioversion

NCT02911545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-09-22

No results posted yet for this study

Summary

Non-vitamin K oral anticoagulants (NOAC) have been shown to be safe and effective alternatives to warfarin for stroke prevention in patients with nonvalvular AF (NVAF). There are yet limited real life data on outcomes following elective cardioversion in AF patients treated with NOACs. The aim of this study is to investigate the complications and the use of NOACs in AF patients undergoing cardioversion.

Conditions

Sponsors & Collaborators

  • University of Turku

    collaborator OTHER

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Mika Lehto, MD, PhD · Helsinki University Central Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2015-12-31
Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911545 on ClinicalTrials.gov